Cargando…

Inferring Homologous Recombination Deficiency of Ovarian Cancer From the Landscape of Copy Number Variation at Subchromosomal and Genetic Resolutions

BACKGROUND: Homologous recombination deficiency (HRD) is characterized by overall genomic instability and has emerged as an indispensable therapeutic target across various tumor types, particularly in ovarian cancer (OV). Unfortunately, current detection assays are far from perfect for identifying e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Meng, Ma, Si-Cong, Tan, Jia-Le, Wang, Jian, Bai, Xue, Dong, Zhong-Yi, Zhang, Qing-Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716765/ https://www.ncbi.nlm.nih.gov/pubmed/34976815 http://dx.doi.org/10.3389/fonc.2021.772604

Ejemplares similares

Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low‐pass whole‐genome sequencing
por: Yu, Dongyi, et al.
Publicado: (2019)

Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology
por: Yao, Huizi, et al.
Publicado: (2023)

Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020)

Regulation of DNA replication on subchromosomal units of mammalian cells
Publicado: (1975)

Subchromosome-Scale Nuclear and Complete Mitochondrial Genome Characteristics of Morchella crassipes
por: Liu, Wei, et al.
Publicado: (2020)

Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial
por: Schouten, Philip C., et al.
Publicado: (2021)

Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes
por: da Costa, Alexandre A. B. A., et al.
Publicado: (2019)

High resolution copy number inference in cancer using short-molecule nanopore sequencing
por: Baslan, Timour, et al.
Publicado: (2021)

GSA: an independent development algorithm for calling copy number and detecting homologous recombination deficiency (HRD) from target capture sequencing
por: Chen, Dongju, et al.
Publicado: (2021)

Clinical outcome of subchromosomal events detected by whole‐genome noninvasive prenatal testing
por: Helgeson, J., et al.
Publicado: (2015)

Subchromosomal Mapping of a Putative Transformation Suppressor Gene on Human Chromosome 1
por: Horikawa, Izumi, et al.
Publicado: (1995)

Nonallelic homologous recombination events responsible for copy number variation within an RNA silencing locus
por: Cho, Young B., et al.
Publicado: (2019)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors
por: Haverty, Peter M, et al.
Publicado: (2009)

CNValidator: validating somatic copy-number inference
por: Smith, Lucian P, et al.
Publicado: (2019)

Reliable detection of subchromosomal deletions and duplications using cell‐based noninvasive prenatal testing
por: Vossaert, Liesbeth, et al.
Publicado: (2018)

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types
por: Shi, Zhiwen, et al.
Publicado: (2023)

Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics
por: Yao, Qianlan, et al.
Publicado: (2022)

Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies
por: Xue, Huili, et al.
Publicado: (2022)

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
por: Wen, Hao, et al.
Publicado: (2022)

Inferring copy number and genotype in tumour exome data
por: Amarasinghe, Kaushalya C, et al.
Publicado: (2014)

Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets
por: Lai, Zhongwu, et al.
Publicado: (2022)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
por: da Cunha Colombo Bonadio, Renata Rodrigues, et al.
Publicado: (2018)

Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
por: Bouberhan, Sara, et al.
Publicado: (2020)

The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
por: van Wijk, Lise M., et al.
Publicado: (2020)

The Landscape of Realized Homologous Recombination in Pathogenic Bacteria
por: Yahara, Koji, et al.
Publicado: (2016)

Accurate Inference of Tumor Purity and Absolute Copy Numbers From High-Throughput Sequencing Data
por: Yuan, Xiguo, et al.
Publicado: (2020)

Population Genomic Sequencing Delineates Global Landscape of Copy Number Variations that Drive Domestication and Breed Formation of in Chicken
por: Chen, Xia, et al.
Publicado: (2022)

Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies
por: Hu, Hua, et al.
Publicado: (2019)

Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score()
por: Feng, Cong, et al.
Publicado: (2023)

Inference of chromosome-specific copy numbers using population haplotypes
por: Huang, Yao-Ting, et al.
Publicado: (2011)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Biomarkers for Homologous Recombination Deficiency in Cancer
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2021)

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
por: Watkins, Johnathan A, et al.
Publicado: (2014)

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
por: Takaya, Hisamitsu, et al.
Publicado: (2020)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
por: Mangogna, Alessandro, et al.
Publicado: (2023)

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma
por: Christinat, Yann, et al.
Publicado: (2023)

Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
por: Liu, Hangqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8uat7atqkglvlus3novqe2e55